Progetti

Investigating the gut microbiome and circulating cytokines as biomarkers to predict efficacy and toxicity of immunotherapy in patients with triple negative breast cancer: a translational analysis of the prospective A-BRAVE randomized trial (MERLIN)

Investigating the gut microbiome and circulating cytokines as biomarkers to predict efficacy and toxicity of immunotherapy in patients with triple negative breast cancer: a translational analysis of the prospective A-BRAVE randomized trial (MERLIN) Read More »

Scroll to Top